The Effectiveness and Safety of HIIT in Overweight Male Subjects

April 13, 2022 updated by: Nani Cahyani Sudarsono, Indonesia University

The Effectiveness and Safety of High Intensity Interval Training Based on Oxidative Stress and Inflammatory Markers in the Management of Overweight Male Subjects

Increased prevalence of overweight and obesity is one of the main health problems recently. Energy balance from nutrition intake and energy expenditure through physical activity, especially structured physical activity, is needed to prevent overweight individuals become obese individuals. This research objective is to explore the effectiveness and safety of structured high intensity interval training in male young adults subjects with overweight based on change of body composition, oxidative stress and inflammatory markers. This research used experimental model to test structured high intensity interval training program with pre-post test in single group. Comprehensive analysis of training effect in this research consists of measurement of several parameters, such as body composition, inflammatory markers, and oxidative stress markers as the benchmark of training safety. Browning white adipose tissue and cognitive function are complement parameters to the assessment of training effectiveness. Daily food record and physical activity for 3 x 24 hours will be carried out periodically to control confounding factors.

Study Overview

Status

Active, not recruiting

Intervention / Treatment

Detailed Description

  • Subjects are recruited via e-flyer distributed online across university departments. Individual who is interested in study participation fills out screening form. Research assistants screen subjects eligibility. Subjects are coded based on the order of screening form fulfillment.
  • Research assistants are using the standard operational procedures for each assessments. Training for the research assistants precedes the data collection to ensure the similarity of understanding and skills during measurements. One research assistant responsible for scheduling the assessments and training sessions. Continuous evaluation are planned weekly to provide room for improvements in the process of data collection.
  • Sample size assessment is measured from 5 primary output by a research assistants using sample size calculation website for single intervention clinical trial.
  • Investigator use paper based data collection for each assessment and during training sessions. Subject are encouraged to report any symptoms and signs during intervention period in each meeting with the research assistants or via online messaging. Any reports will be documented in separated form. One research assistant makes sure the data fields are completed in each measurements and during training sessions. The assistant also check the similarity of the data entered in the master table.
  • Data analysis will be lead by one research assistant using newest version of SPSS software. The analysis will be started after the baseline measurement is completed although the data collection is not finished. All numeric data will be presented as mean and standard deviations if normally distributed or median and minimum maximum range if not normally distributed. Paired t-test will be used to identify the difference before and after the intervention if the data are normally distributed. If the data are not normally distributed, Wilcoxon test will be used to identify the difference before and after the intervention.

To ensure that there is no missing data, the research assistant who responsible for data completeness will perform daily checking. Any missing data will be stated and immediately completed. Research assistants will provide close supervision for each subject to ensure the delivery of all necessary reports.

Study Type

Interventional

Enrollment (Actual)

16

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • DKI Jakarta
      • Jakarta Pusat, DKI Jakarta, Indonesia, 10430
        • Fakultas Kedokteran Universitas Indonesia
      • Jakarta Pusat, DKI Jakarta, Indonesia, 10430
        • Universitas Indonesia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • overweight (BMI 25 - 29,9)
  • live in Jakarta and greater area
  • willing to participate

Exclusion Criteria:

  • smoking
  • any medical health problems (epilepsy, cardiovascular disease, kidney and liver problems, history of fractures, tendon and ligament injuries)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High Intensity Interval Training
single arm intervention, with high intensity interval training
3x/week high intensity interval training for 12 weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
cardiorespiratory fitness
Time Frame: 12 weeks
VO2Max in ml/kg/minute
12 weeks
body mass index
Time Frame: week 4
weight and height combined as BMI in kg/m2
week 4
body mass index
Time Frame: week 8
weight and height combined as BMI in kg/m2
week 8
body mass index
Time Frame: week 12
weight and height combined as BMI in kg/m2
week 12
body fat mass
Time Frame: week 4
total fat mass in the body as percentage
week 4
body fat mass
Time Frame: week 8
total fat mass in the body as percentage
week 8
body fat mass
Time Frame: week 12
total fat mass in the body as percentage
week 12
visceral fat
Time Frame: week 4
body fat stored within abdominal cavity as ratings
week 4
visceral fat
Time Frame: week 8
body fat stored within abdominal cavity as ratings
week 8
visceral fat
Time Frame: week 12
body fat stored within abdominal cavity as ratings
week 12
waist circumference
Time Frame: week 4
circumference measured in the horizontal plane midway between the lowest ribs and the iliac crest as cm
week 4
waist circumference
Time Frame: week 8
circumference measured in the horizontal plane midway between the lowest ribs and the iliac crest as cm
week 8
waist circumference
Time Frame: week 12
circumference measured in the horizontal plane midway between the lowest ribs and the iliac crest as cm
week 12
lipid profile
Time Frame: 12 weeks
total cholesterol, HDL cholesterol, LDL cholesterol, triglyceride
12 weeks
antioxidant level
Time Frame: 12 weeks
SOD in U/mg
12 weeks
free radicals level
Time Frame: 12 weeks
MDA in nmol/mg
12 weeks
inflammation
Time Frame: 12 weeks
TNF-alpha in microgram/ml
12 weeks
interleukin level
Time Frame: 12 weeks
IL-6 nanogram/ml
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fat Burning Effect
Time Frame: week 1, 6, 12
FGF21
week 1, 6, 12
Myokin
Time Frame: week 1, 6, 12
Irisin
week 1, 6, 12
Cognitive Function Screening
Time Frame: week 1 and 12
Montreal Cognitive Assessment as score
week 1 and 12
Working memory Capacity
Time Frame: week 1 and 12
N-Back test as percentage of correct answers
week 1 and 12
Executive Function
Time Frame: week 1 and 12
Trail Making Test A and B as seconds
week 1 and 12

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nani Sudarsono, Fakultas Kedokteran Universitas Indonesia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2020

Primary Completion (Actual)

October 30, 2021

Study Completion (Anticipated)

September 30, 2022

Study Registration Dates

First Submitted

May 29, 2021

First Submitted That Met QC Criteria

August 3, 2021

First Posted (Actual)

August 11, 2021

Study Record Updates

Last Update Posted (Actual)

April 21, 2022

Last Update Submitted That Met QC Criteria

April 13, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 20-09-1081

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Overweight

Clinical Trials on HIIT

Subscribe